journal article·2026-12-31Open access

Assessment of the safety and efficacy of micronized encapsulated ferric pyrophosphate in patients with iron deficiency anaemia: a phase-IV open-label clinical study

Belal Almajali, Giriraja KV, Gowthamarajan Kuppusamy, Md. Zeyaullah, Nayudu Teja, Veera Venkata Satyanarana Reddy Karri, Mohamed Rahamathulla, Muhammad Ali Abdullah Almoyad, Khursheed Muzammil, Mohammed Muqtader Ahmed, Ismail Pasha

Abstract

An open-level, single-arm, phase-4 clinical trial was carried out to assess the safety and potential benefits of micronized coated ferric pyrophosphate (MEFP) in patients with iron deficiency anaemia (IDA). For 12 weeks, 60 patients between the ages of 18 and 60 with moderate IDA were randomly received MEFP by PO daily. The efficacy endpoints as haemoglobin levels, mean corpuscular haemoglobin (MCH), mean cell haemoglobin concentration (MCHC), packed cell volume (PCV), red blood cell count (RBC), serum ferritin and transferrin saturation (%) were measured. Adverse event reports and physical examinations were performed as a measure of safety assessment. The results revealed that haemoglobin, MCV, MCHC, serum ferritin, transferrin saturation (%), PCV and RBC increased significantly from baseline. Fewer occurrences were observed in a few patients, and their adverse events were minimal. There was no adverse effect on liver or renal functions. Few minor improvements were noticed at the completion of the study. In conclusion, MEFP appears to be effective in IDA and well tolerated, with a favourable safety profile. MEFP is an effective, safe therapeutic alternative in IDA subjects for increasing haemoglobin concentration and iron stores along with improvement of symptoms related to anaemia.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Iron Metabolism and Disorders · Erythropoietin and Anemia Treatment · Hemoglobinopathies and Related Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University

Rajalakshmi Hospital

Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research

Department of Basic Medical Science, College of Applied Medical Sciences, Khamis Mushayt Campus, King Khalid University

Department of Pharmaceutics, College of Pharmacy, King Khalid University

Department of Public Health, College of Applied Medical Sciences, Khamis Mushait Campus, King Khalid University

Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdul Aziz University

Department of Pharmacology, Orotta college of medicine and Health Science

Funding

King Khalid University, Saudi Arabia

References (32)

Show source-provided references
1. 10.1017/S136898000800240110.1017/S1368980008002401 ↗
2. 10.3390/nu1414297610.3390/nu14142976 ↗
3. 10.1038/s41598-022-12258-610.1038/s41598-022-12258-6 ↗
4. 10.5812/ijp-12293710.5812/ijp-122937 ↗
5. 10.54319/jjbs/17031110.54319/jjbs/170311 ↗
6. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anaemia burden from. To 2010. Blood, the Journal of the American Society of Hematology. 1990;123(5):615–624.
7. 10.1016/j.ijgo.2014.09.02710.1016/j.ijgo.2014.09.027 ↗
8. 10.1182/blood-2017-07-74644610.1182/blood-2017-07-746446 ↗
9. 10.1111/joim.1300410.1111/joim.13004 ↗
10. 10.1016/j.clnesp.2022.08.03210.1016/j.clnesp.2022.08.032 ↗
11. 10.7324/JAPS.2024.17222710.7324/JAPS.2024.172227 ↗
12. 10.1111/j.1365-2621.2003.tb07031.x10.1111/j.1365-2621.2003.tb07031.x ↗
13. 10.1079/bjn2004101810.1079/bjn20041018 ↗
14. 10.1093/ajcn/80.4.95210.1093/ajcn/80.4.952 ↗
15. 10.1093/jn/136.7.181410.1093/jn/136.7.1814 ↗
16. 10.2450/2017.0113-1710.2450/2017.0113-17 ↗
17. 10.1111/j.1523-1755.2005.00758.x10.1111/j.1523-1755.2005.00758.x ↗
18. 10.1159/00008504910.1159/000085049 ↗
19. 10.1053/j.ajkd.2009.12.03010.1053/j.ajkd.2009.12.030 ↗
20. 10.7326/M14-293210.7326/M14-2932 ↗
21. 10.1080/1528739800952988810.1080/15287398009529888 ↗
22. 10.1007/BF0031850110.1007/BF00318501 ↗
23. 10.3390/nu1304108710.3390/nu13041087 ↗
24. 10.18203/2349-3259.ijct2018125710.18203/2349-3259.ijct20181257 ↗
25. 10.18203/2320-1770.ijrcog2024281010.18203/2320-1770.ijrcog20242810 ↗
26. Kailashnath BS, Indrani CI. A comparative study between ferric pyrophosphate and ferrous ascorbate In pregnant women with anemia in a tertiary care centre. Res J Pharmaceutical, Biological and Chem Sci. 2023;14(4):243.
27. 10.18502/ijpho.v11i2.584010.18502/ijpho.v11i2.5840 ↗
28. 10.3390/metabo1205046310.3390/metabo12050463 ↗
29. 10.2450/2007.0021-0710.2450/2007.0021-07 ↗
30. 10.2450/2019.0181-1810.2450/2019.0181-18 ↗
31. 10.3389/fmicb.2017.0074910.3389/fmicb.2017.00749 ↗
32. 10.26355/eurrev_201806_1518710.26355/eurrev_201806_15187 ↗